Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 3616 AL 3630

Cognitive and behavioural inhibition deficits in neurodegenerative dementias

Migliaccio R, Tanguy D, Bouzigues A, Sezer I, Dubois B, Le Ber I, Batrancourt B, Godefroy V, Levy R.

Cortex. 2020 Oct;131:265-283. doi: 10.1016/j.cortex.2020.08.001. Epub 2020 Aug 10.

Is Deep Brain Stimulation Associated With Detrimental Effects on Cognitive Functions in Patients of Parkinson's Disease? A Systematic Review

Maheshwary A, Mohite D, Omole JA, Bhatti KS, Khan S.

Cureus. 2020 Aug 12;12(8):e9688. doi: 10.7759/cureus.9688.

The Neurodevelopmental Hypothesis of Huntington's Disease

van der Plas E, Schultz JL, Nopoulos PC.

J Huntingtons Dis. 2020;9(3):217-229. doi: 10.3233/JHD-200394.

Large Animal Models of Huntington's Disease: What We Have Learned and Where We Need to Go Next

Howland D, Ellederova Z, Aronin N, Fernau D, Gallagher J, Taylor A, Hennebold J, Weiss AR, Gray-Edwards H, McBride J.

J Huntingtons Dis. 2020;9(3):201-216. doi: 10.3233/JHD-200425.

From Seeds to Fibrils and Back: Fragmentation as an Overlooked Step in the Propagation of Prions and Prion-Like Proteins

Marrero-Winkens C, Sankaran C, Schätzl HM.

Biomolecules. 2020 Sep 10;10(9):1305. doi: 10.3390/biom10091305.

Management of Agitation in Huntington's Disease: A Review of the Literature

Rossi G, Oh JC.

Cureus. 2020 Aug 14;12(8):e9748. doi: 10.7759/cureus.9748.

The role of nutraceuticals as a complementary therapy against various neurodegenerative diseases: A mini-review

Chiu HF, Venkatakrishnan K, Wang CK.

J Tradit Complement Med. 2020 Apr 1;10(5):434-439. doi: 10.1016/j.jtcme.2020.03.008. eCollection 2020 Sep.

Special Issue: Juvenile Onset Huntington's Disease

Nopoulos PC.

Brain Sci. 2020 Sep 20;10(9):652. doi: 10.3390/brainsci10090652.

Chorea gravidarum associated with systemic lupus erythematosus and antiphospholipid syndrome: case report

Godínez-Baca LE, Lugo-Zamudio GE, Maya-Piña LV.

Cir Cir. 2020;88(Suppl 1):59-62. doi: 10.24875/CIRU.19001503.

Blood Oxidative Stress Marker Aberrations in Patients with Huntington's Disease: A Meta-Analysis Study

Tang Q, Liu H, Shi XJ, Cheng Y.

Oxid Med Cell Longev. 2020 Sep 8;2020:9187195. doi: 10.1155/2020/9187195. eCollection 2020.

Gene therapy for neurodegenerative disorders: advances, insights and prospects

Chen W, Hu Y, Ju D.

Acta Pharm Sin B. 2020 Aug;10(8):1347-1359. doi: 10.1016/j.apsb.2020.01.015. Epub 2020 Jan 31.

Implications of the Orb2 Amyloid Structure in Huntington's Disease

Hervás R, Murzin AG, Si K.

Int J Mol Sci. 2020 Sep 21;21(18):6910. doi: 10.3390/ijms21186910.

White matter and neurological disorders

Bae HG, Kim TK, Suk HY, Jung S, Jo DG.

Arch Pharm Res. 2020 Sep;43(9):920-931. doi: 10.1007/s12272-020-01270-x. Epub 2020 Sep 25.

Critical Impact of Different Conserved Endoplasmic Retention Motifs and Dopamine Receptor Interacting Proteins (DRIPs) on Intracellular Localization and Trafficking of the D(2) Dopamine Receptor (D(2)-R) Isoforms

Blagotinšek Cokan K, Mavri M, Rutland CS, Glišić S, Senćanski M, Vrecl M, Kubale V.

Biomolecules. 2020 Sep 23;10(10):1355. doi: 10.3390/biom10101355.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias